Plasmids and cloning
We used plasmids carrying the genetically encoded potassium sensor lc-LysM GEPII 1.0 with different subcellular targeting sequences as previously described21. The sensor was targeted either to the cytosol (cyto), the plasma membrane (SubPM), or the mitochondria (mito). To achieve AAVmediated expression, we subcloned the ORFs encoding the different variants of lc-LysM GEPII 1.0 in AAV backbones under the control of a CAG promoter for ubiquitous expression (pAAV-CAG-GFP, Addgene #37825), a hSyn promoter for neuronal expression (pAAV-hSyn-eGFP, Addgene #50465) or a GFAP promoter for astrocytic expression (pAAV.GFAP.iGABASnFr, Addgene #112172). All three backbones were linearized by cutting out the existing transgenes using BamHI and HindIII restriction sites. These restriction sites were added to cyto-lc-LysM GEPII 1.0 and SubPM-lc-LysM GEPII 1.0 via overhang PCR to insert them directly via subcloning. Since mito-lc-LysM GEPII 1.0 contains a BamHI restriction site, this transgene was inserted using the Gibson Assembly method. After cloning, DNA was transformed into competent DH5α E. coli bacteria, colonies were screened via colony PCR and candidate clones were confirmed by sequencing before amplification and AAV production.
pAAV.Syn.NES-jRCaMP1b.WPRE.SV40 was a gift from Douglas Kim & GENIE Project (Addgene plasmid # 100851; http://n2t.net/addgene:100851; RRID: Addgene_100851). For bacterial expression of jRCaMP1b, the construct was subcloned into EKAR2G_design1_mTFP_wt_Venus_wt vector (Addgene plasmid # 39813) using the restriction sites BamHI and XhoI.
For imaging the concentration of cytosolic calcium ions in vitro, we used pGP-AAV-syn-jGCaMP8m-WPRE, a gift from the GENIE Project (Addgene plasmid #162375)22. For optogenetic stimulation, we used pAAV-Syn-ChrimsonR-tdT, a gift from Edward Boyden (Addgene plasmid #59171)23.
Protein purification:
Bacterial expression plasmids containing lc-LysM GEPII 1.0 and jRCaMP1b were transformed into Rosetta (DE3) competent cells. For the selection of lc-LysM GEPII 1.0 and jRCaMP1b positive cells, kanamycin and ampicillin were used, respectively. For purification of the biosensors, positive clones were inoculated in 5 mL LB with appropriate antibiotic, and after 8 hours, the cultures were transferred into 250 mL LB plus antibiotic and incubated at 37°C. At an OD value between 0.4 and 0.6 protein expression was induced using IPTG with a final concentration of 0.5 mM and further incubated for 16 hours at 18°C. Purification of the 6x histidine-tagged biosensors was performed using gravity-based Ni-NTA affinity chromatography method as described elsewhere24. Purified proteins were concentrated using Ultracel® Regenerated Cellulose (30kDa MWCO) Amicon tubes and kept at -80°C for further usage. The functionality of the purified biosensors was tested using a SpectraMax i3 Multi-Mode Microplate Reader. Samples were loaded on a 96-well plate with a solid black bottom. The intensiometric calcium biosensors jRCaMP1b were excited at 535/25 nm and emission was collected at 595/35 nm. The FRET-based biosensors lc-LysM GEPII 1.0 were excited with 430/9 nm and emission was collected at 485/9-535/15 nm, respectively.
AAV Production
Adeno-associated viral particles were produced in HEK293T cells grown in DMEM supplemented with 10% FBS and 100 U/mL Penicillin-Streptomycin in a humidified incubator at 37°C/5% CO2. Cells were grown to 70–80% confluency and triple transfected with pHelper, pAAV-DJ (both from Cell Biolabs, Cat: VPK-400-DJ) and a pAAV-ITR-vector carrying the transgene. Triple transfection was achieved using polyethylenimine (PEI) titrated to pH 7.0. Two to three days after transfection, cells were detached using 1/80 of the culture volume of 0.5 M EDTA in PBS pH 7.4 and AAV particles were extracted using the AAVpro® Purification Kit (All serotypes) from Takara Bio Inc. (Cat: #6666). Cells were centrifuged at 1700 g for 10 min at 4°C and the supernatant was discarded. The resulting cell pellet was lysed by vortexing it with 650 µL of AAV Extraction Solution A plus. Subsequently, cell debris was pelleted at 14 000 g for 10 min at 4°C and the supernatant was collected in a new tube. Finally, 65 µL of AAV Extraction Solution B was added, and the viral solution was aliquoted and stored for further use at -80°C. AAV titration was performed by qPCR using the AAVpro® Titration Kit (for RealTime PCR) Ver.2 from Takara (Cat: #6233) according to the manufacturer’s instructions. Titration was performed using primers that annealed in the ITR repeats of the viral backbone (ITR F: GGAACCCCTAGTGATGGAGTT and ITR R: CGGCCTCAGTGAGCGA).
Preparation of cryo-stocks of mixed cortical cultures
Cryopreserved mixed cortical cell culture stocks were prepared from E17 embryos of Sprague Dawley rats. Brains were removed and immediately placed in ice-cold HBSS supplemented with 7 mM HEPES pH 7.4. Cortices were dissected, meninges were removed, and the tissue was cut into small pieces with a scalpel. Then the tissues from all embryos of one litter were digested in HBSS supplemented with 0.5% Trypsin and 10 µg/mL DNAse I for 15 min at 37°C. Digestion was stopped by the addition of MEM supplemented with 10% FBS, the tissue was washed twice with HBSS and subsequently triturated using a glass Pasteur pipette coated with 4% BSA in HBSS. After counting the concentration of cells in the suspension, the cell suspension was diluted with MEM supplemented with 10% FBS to 2 million cells per mL. Finally, DMSO was added to a volume fraction of 10% and the solution was aliquoted. Aliquots were cryopreserved by placing them in a freezing container filled with isopropanol at -80°C over night. The next morning, the aliquots were transferred into a liquid nitrogen tank for longterm storage.
Mixed cortical cell cultures from cryo-stocks
All cell culture reagents were purchased from Gibco. Mixed cortical cultures were plated on 15 mm round glass cover slips coated with PolyDLysine at a density of 100,000 cells per cover slip. A cryopreserved aliquot was thawed at 37°C and diluted in an appropriate amount of culture medium (Neurobasal-A medium, no D-glucose, no sodium pyruvate supplemented with 1x B27, 10 mM glucose, 2 mM GlutaMAX™, 1 mM sodium pyruvate and 100 U/mL Penicillin-Streptomycin). The cell suspension was plated on the coverslips placed in 12-well plates and maintained in a humidified incubator at 37°C/5% CO2. Half of the culture medium was replaced twice a week and cells were used after 22–24 days. For transgene expression, cells were transduced 3–4 days before the experiment with the appropriate AAV at a MOI of 1000.
Immunostainings
For immunocytochemistry, mixed cortical cultures were washed with PBS and subsequently incubated with 4% paraformaldehyde (PFA)/4% sucrose in PBS for 15 min at room temperature (RT). Fixed cells were washed three times with PBS, incubated with 50 µM NH4Cl in PBS for 10 min at RT, followed by another three washes with PBS. Fixed cells were then permeabilized using 0.1% TritonX in PBS for 3 min at RT and blocked with blocking buffer (0.2% BSA, 0.2% FCS, 0.02% fish-skin gelatin in PBS) for 1 h at RT. Subsequently, cultures were incubated with primary antibodies against gp-NeuN (Synaptic Systems, 266 004) and mouse-GFAP (Cell Signaling, #3670) diluted in blocking buffer for 2 h at RT. Subsequently, primary antibodies were removed, cells were washed 3 times with PBS for 5 min and then incubated with anti-guinea pig- AlexaFluor® 647 (Jackson, 706-606-148) and anti-mouse AlexaFluor® 594 (Jackson, 715-586-150) diluted in blocking buffer for 1 h at RT. During the last 5 minutes of this step, DAPI (5 µg/mL) was added to stain the nuclei. Finally, coverslips were washed three times with PBS for 5 min each and mounted on microscopy slides. Cells were imaged at a confocal microscope.
For immunohistochemistry, animals virally transduced with AAV-hSyn-lc-LysM GEPII 1.0 were anesthetized with MMF and transcardially perfused with PBS followed by 4% PFA in PBS until the liver was devoid of blood. Brains were extracted, post-fixed in 4% PFA in PBS overnight and then stored in PBS at 4°C until further use. Brains were mounted in 4% agarose and sectioned using a vibratome to create 100 µm thick brain slices. PFA-fixed brain sections were incubated in a blocking and permeabilizing primary antibody buffer solution (1% BSA, 0.1% fish-skin gelatin, 0.1% Triton X-100, 0.05% Tween 20 in PBS) with rabbit anti-NeuN (Abcam, ab177487) antibodies at 1:100 dilution on a rotary shaker at 4°C for 2–3 days. Sections were then washed in PBS three times for 30 minutes and incubated with a secondary antibody buffer mix (0.2% BSA, 0.2% FCS, 0.02% fish-skin gelatin in PBS) containing 1:300 anti-rabbit AlexaFluor® 647 (Jackson, 711-606-152) antibody at 4°C on a rotary shaker for two days. Sections were then washed three times in PBS and during the last washing step, DAPI was added at a concentration of 5 µg/mL for 30 minutes to stain the nuclei. Washing using PBS was repeated three times for 30 minutes prior to mounting the sections on glass coverslips. Brain section overviews were imaged with a confocal microscope using a 10x air objective.
Live cell imaging
For live cell imaging of mixed cortical cultures expressing either GCaMP8m or lc-LysM GEPII 1.0, coverslips with the cultures were transferred in an open imaging chamber and placed on an inverted microscope. The microscope was equipped with a 20x air objective (NA 0.8), an LED light source, an emission image splitter, and a CCD camera. Cells were constantly superfused with aCSF (in mM: 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 1 MgCl2, 1.25 CaCl2, 2 glucose, 0.5 sodium lactate, 0.05 sodium pyruvate) gassed with 5% CO2/95% air to maintain a stable pH at room temperature. GCaMP8m was excited with 10 Hz at 469 ± 19 nm and emission was collected with a bandpass filter at 525 ± 25 nm. For FRET imaging of lc-LysM GEPII 1.0, cells were excited at 436 ± 10 nm and emitted light was split at 515 nm on the camera for simultaneous recording of mseCFP and cpV using a dichroic mirror (t515lp, Chroma). Emission of the individual channels was collected using bandpass filters (480 ± 15 nm for mseCFP, 535 ± 15 nm for cpV). Depending on the experiment, cells expressing lc-LysM GEPII 1.0 were excited with frequencies ranging from 0.2 to 10 Hz. Exposure time, LED power, and excitation frequencies were adjusted to minimize bleaching and phototoxicity while still obtaining sufficient signal-to-noise ratio. The remaining bleaching was corrected using a customwritten Python script and the data was represented as FRET ratio cpV/mseCFP.
Optogenetic stimulation
For optogenetic stimulation, we co-transduced cultures with AAV-Syn-ChrimsonR-tdT and either AAV-CAG-lc-LysM GEPII 1.0 or AAV-Syn-GCaMP8. Optogenetic stimulation was achieved by placing a red LED (M617L4, Thorlabs) over the cells during imaging using a custom-made 3Dprinted holder. To maximize stimulation strength, the emitted light was collected using an aspheric condenser lens. A custom-made microcontroller-gated LED driver allowed programmable and precise light pulses for stimulation. Cells were stimulated with trains of 10 ms light pulses at 1 Hz, allowing enough time in between stimulation trains for complete recovery of the signal.
To avoid imaging artifacts from the stimulation light, a 590 nm long pass filter was placed in front of the LED and additional 550 nm short pass filters were added in the emission light path. The intensity of the excitation light for either GCaMP8m or lc-LysM GEPII 1.0 was minimized to avoid cross-stimulation of ChrimsonR. If the minimal LED power led to neuronal stimulation, it was further reduced using a neutral density filter OD 1.3.
Animals
Two to three months old male C57BL/6J mice were used. The animals were group-housed under pathogen-free conditions and bred in the animal housing facility of the Center of Stroke and Dementia Research, with food and water provided ad libitum (21 ± 1°C, at 12/12-hour light/dark cycle). All experiments were carried out in compliance with the ARRIVE guidelines, the National Guidelines for Animal Protection, Germany and with the approval of the regional Animal Care Committee of the Government of Upper Bavaria.
Cranial window implantation and stereotactic virus injection
Before use, surgical tools were sterilized in a glass-bead sterilizer (Fine Science Tools). Mice were anesthetized by an i.p. injection of medetomidine (0.5 mg/kg), midazolam (5 mg/kg), and fentanyl (0.05 mg/kg). Subsequently, mice were placed onto a heating blanket (37°C), and the head was fixed in a stereotactic frame. Eyes were protected from drying by applying eye ointment. The scalp was washed with swabs soaked with 70% ethanol. A flap of skin covering the cranium was excised using small scissors. The periosteum was scraped away with a scalpel. The prospective craniotomy location over the somato-sensory cortex was marked with a biopsy punch (diameter 4 mm). The exposed skull around the area of interest was covered with a thin layer of dental acrylic (iBond Self Etch, Heraeus Kulzer) and hardened with an LED polymerization lamp (Demi Plus, Kerr). A dental drill (Schick Technikmaster C1, Pluradent) was used to thin the skull around the marked area. After applying a drop of sterile phosphate buffered saline on the craniotomy, the detached circular bone flap was removed with forceps. Subsequently, 0.5 µl of a virus suspension (AAV.PhPeb-Syn.NES- lc-LysM GEPII 1.0, Vectorbuilder and AAV.9-Syn.NES-jRCAMP1b, Addgene #100851-AAV9 mixed 1:1 to a final concentration of 1x1012 vg/ml) was injected via a glass capillary and Nanoliter 2020 Injector (World Precision Instruments) at a speed of 50 nl/min into the somatosensory cortex at the following coordinates: -1.5 mm rostrocaudal, -1.5 mm lateral and − 0.25 mm dorsoventral. A circular coverslip (4 mm diameter) was placed onto the craniotomy and glued to the skull with histoacryl adhesive (Aesculap). The exposed skull was covered with dental acrylic (Tetric Evoflow A1 Fill, Ivoclar Vivadent), and a head-post was attached parallel to the window for head-fixing mice in subsequent imaging sessions. After surgery, mice received a s.c. dose of the analgesic Carprophen (7.5 mg/kg body weight). Anesthesia was antagonized using Atipamezol (2.5 mg/kg), Naloxone (1.2 mg/kg), and Flumazenil (0.5 mg/kg) i.p. Finally, mice were allowed to recover in a 35°C warming chamber until full recovery. In vivo imaging was commenced three to four weeks after surgery.
Mouse cerebral ischemia model
For remote occlusion of the middle cerebral artery (MCAo) in mice25 the left common carotid artery was exposed and the superior thyroid artery branching was cauterized. The common carotid artery was ligated and the external carotid artery (ECA) was fully occluded. A filament with a diameter of 0.21 ± 0.02 mm (6021PK10, Doccol Corporation, Sharon, MA, USA) was inserted through as small incision into the ECA and advanced for 5 mm. A custom-made occlusion filament was inserted into the ECA while the Doccol filament was simultaneously removed. The filament was then further advanced along the internal carotid artery towards the middle cerebral artery (MCA). After placing the under the 2-photon microscope the MCA could be occluded remotely. MCA occlusion (MCAo) caused a cortical infarct which induced periinfarct depolarizations waves (PIDs) within the surrounding tissue.
In vivo two-photon microscopy
In vivo two-photon imaging was performed three weeks after cranial window implantation using a Leica SP8 DIVE 2-photon microscope equipped with a fs-laser, a 25x water immersion objective and a motorized stage. lc-LysM GEPII 1.0 and jRCaMP1b were co-excited at 850 nm and 1045 nm, respectively, and the emission was collected at 450–500 nm and 575–625 nm with non-descanned detectors placed directly behind the objective. Laser power below the objective was kept around 50 mW to minimize phototoxicity. Throughout the imaging session, mice were anesthetized with isoflurane (1% in oxygen, 0.5 l/min) and kept on a heating pad to maintain body temperature at 37°C. XY time-lapse series (7.51 Hz) with 1 µm axial resolution and 128 x 128 pixels per image frame of lc-LysM GEPII 1.0 and jRCaMP1b expressing neurons were subsequently recorded at a depth of 150–200 µm underneath the cortical surface. After 5 min of baseline recordings, periinfarct depolarizations were induced via remote MCAo and recordings were continued for further 10 min. Fluorescence lifetime measurements were subsequently analyzed in LAS X (Leica).